2023-2024 Regular Session • Delaware Legislature
HB383: An Act To Amend Titles 18 And 24 Of The Delaware Code Relating To Prohibiting Discrimination Against 340b Drugs And Covered Entities By Manufacturers And Pharmacy Benefits Managers.
Legislative Summary
This substitute for House Bill 383 does the following:
Bill History
6/6/2024
was introduced and adopted in lieu of HB 383
6/13/2024
Amendment HA 1 to HS 1 - Introduced and Placed With Bill
6/13/2024
Amendment HA 2 to HS 1 - Introduced and Placed With Bill
6/13/2024
Amendment HA 1 to HS 1 - Passed In House by Voice Vote
6/13/2024
Amendment HA 2 to HS 1 - Passed In House by Voice Vote
6/13/2024
Passed By House. Votes: 37 YES 1 NO 3 ABSENT
6/13/2024
Assigned to Banking, Business, Insurance & Technology Committee in Senate
6/29/2024
Amendment SA 1 to HS 1 - Introduced and Placed With Bill
6/30/2024
Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 On Its Merits
6/30/2024
Amendment SA 1 to HS 1 - Passed By Senate. Votes: 21 YES
6/30/2024
Passed By Senate. Votes: 21 YES
6/30/2024
Passed By House. Votes: 40 YES 1 ABSENT
9/19/2024
Signed by Governor
Roll Call Votes
Senate Third Reading
6/30/2024
21
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House Third Reading
6/30/2024
40
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED
House Third Reading
6/13/2024
37
Yea
1
Nay
0
Not Voting
3
Absent
Result: PASSED
Status Information
Current Status
Passed(9/19/2024)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Democrat: 13
Primary Sponsor
Kerri Harris
Democrat